Dr. Michael Brit
Rheumatology (Rheumatology Physician)
- Medicare participating
At a glance
- Years since graduation
- 37
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 254
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Rheumatology Physician primary
TN license 38107
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Erlanger Medical Center Chattanooga, TN
Medical groups
- Erlanger Health (507 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 254
- Services billed
- 3,190
- Patients’ average age
- 72
| Service | Times | Patients |
|---|---|---|
| Injection, denosumab, 1 mg | 1,380 | 15 |
| Established patient office or other outpatient visit, 30-39 minutes | 281 | 180 |
| New patient office or other outpatient visit, 45-59 minutes | 74 | 74 |
| Established patient office or other outpatient visit, 20-29 minutes | 74 | 63 |
| Injection, methylprednisolone acetate, 80 mg | 30 | 23 |
| Aspiration and/or injection of fluid from large joint | 28 | 20 |
| Injection, methylprednisolone acetate, 40 mg | 27 | 15 |
| Injection of drug or substance under skin or into muscle | 24 | 16 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Hydroxychloroquine Sulfate Other prescribers in Chattanooga, TN | 682 |
| Methotrexate (methotrexate sodium) Other prescribers in Chattanooga, TN | 645 |
| Hydrocodone-Acetaminophen (hydrocodone/acetaminophen) Other prescribers in Chattanooga, TN | 529 |
| Prednisone Other prescribers in Chattanooga, TN | 406 |
| Alendronate Sodium Other prescribers in Chattanooga, TN | 382 |
| Allopurinol Other prescribers in Chattanooga, TN | 160 |
| Humira(Cf) Pen (adalimumab) Other prescribers in Chattanooga, TN | 154 |
| Celecoxib Other prescribers in Chattanooga, TN | 114 |
| Leflunomide Other prescribers in Chattanooga, TN | 111 |
| Folic Acid Other prescribers in Chattanooga, TN | 107 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 15 companies reported 99 payments worth $1,909 in total to this clinician.
| Janssen Biotech, Inc. | $307 |
|---|---|
| Novartis Pharmaceuticals Corporation | $291 |
| AbbVie Inc. | $263 |
| Amgen Inc. | $187 |
| UCB, Inc. | $179 |
| GlaxoSmithKline, LLC. | $126 |
| AstraZeneca Pharmaceuticals LP | $104 |
| Radius Health, Inc. | $83.84 |
| Food and Beverage | $1,832 |
|---|---|
| Education | $76.99 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Janssen Biotech, Inc. May 28, 2025 | Education TREMFYA · Immunology · in-kind | $76.99 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.